Digital Air Strike Expands CX Inventory Merchandising Technology Solutions with Google Vehicle Ads
Dealerships Dominate Search and Social Platforms with Advanced Vehicle Details Page (VDP), In-Market Shopper Targeting,…
Dealerships Dominate Search and Social Platforms with Advanced Vehicle Details Page (VDP), In-Market Shopper Targeting,…
NEW YORK–(BUSINESS WIRE)–The law firm of Kirby McInerney LLP announces that a class action lawsuit…
BOSTON, June 08, 2022 (GLOBE NEWSWIRE) — Cerevance, a private, clinical-stage drug discovery and development…
Meeting adjourned to July 6, 2022 at 9:30 a.m. PT Vaxart encourages all stockholders of…
Virtual concert features a hologram and immersive environment built on Verizon 5G Ultra Wideband and…
ANNAPOLIS, Md., June 08, 2022 (GLOBE NEWSWIRE) — South River Technologies, Inc. (SRT) today announced…
Streamlines the way users fill, create and save their credentials and information online BOSTON, June…
Vancouver, British Columbia–(Newsfile Corp. – June 8, 2022) – Infinity Stone Ventures Corp. (CSE: GEMS)…
DOVER, DE, Jun 8, 2022 – (ACN Newswire) – Pacific Green Technologies, Inc. (the “Company”…
Singapore, Jun 8, 2022 – (ACN Newswire) – OTS Holdings Limited (“OTS Holdings” or the…
LOS ANGELES–(BUSINESS WIRE)–Westlake Capital Finance (WCF), the commercial lending entity & subsidiary of Westlake…
Double-Blind, Peer-Reviewed Study Presented at 2022 ACSM Annual Meeting Photo 1 UBN RELIEF™ is clinically…
BERKELEY HEIGHTS, N.J., June 08, 2022 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical…
Regulatory submission for the label extension is supported by positive data from the pivotal Phase…
RMAT Designation Follows Positive Data from ALLO-501A ALPHA2 Trial in Heavily Pretreated Patients with Relapsed…
– Five abstracts accepted, long-term data confirmed durable efficacy with Bylvay™ (odevixibat), with demonstrated improvement…
Dosing has commenced in HMNC Brain Health and Develco Pharma’s Phase 2 oral prolonged-release Ketamine…
ATLANTA, June 08, 2022 (GLOBE NEWSWIRE) — Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global…
– Enrollment completed ahead of schedule for APOLLO-CD Phase 2a study of PRA023 in Crohn’s…
SEATTLE, June 08, 2022 (GLOBE NEWSWIRE) — Impel Pharmaceuticals Inc. (NASDAQ: IMPL), a commercial-stage pharmaceutical…